A limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation.
View the video series and find out more information here: www.citeline.com/biotech
The State of Play in Biotech and the Decisions Shaping the Industry
Biotech leaders are navigating disciplined growth, shifting global dynamics, and rising expectations across boards, partners, and clinical teams. In this opening episode, a panel of experienced biotech executives step back to discuss where the industry truly stands, the forces shaping decision‑making, and how leaders are approaching strategy, execution, and collaboration in today’s biotech landscape.
Featuring:
- Claire Riches, VP, Clinical Solutions, Citeline
- Ross Pettit, Chief Development Officer, Kestrel Therapeutics
- Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus
- Marrissa Volpe, SVP, Clinical Development, NervGen
- Jennifer Burg, SVP, Clinical Development Operations, Axonis Therapeutics
View the video series and find out more information here: https://www.citeline.com/biotech
26 Jun 2026
Elevate Clinical Operations into a Board Level Strategic Advantage
Clinical operations plays a decisive role in execution quality, data integrity, cost control, and development speed, yet it is often treated as a cost centre rather than a strategic function. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Executive Consultant, Clinical Development Operations to discuss why clinical operations must be elevated into board‑level conversations. Together, they explore how clinops drives value, manages risk, and shapes long‑term development strategy, and what boards and executives need to understand to make better, more informed decisions.
View the video series and find out more information here: https://www.citeline.com/biotech
25 May 2026
Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design
"Biotechs are running increasingly complex clinical trials with lean teams, tight budgets, and growing pressure to deliver faster results. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus to explore how smarter outsourcing, stronger CRO partnerships, and patient‑focused trial design can improve execution, control costs, and reduce operational risk, while avoiding unnecessary burden on sites and participants.
View the video series and find out more information here: https://www.citeline.com/biotech"
23 Apr 2026
Redefine Modern Biotech Through Smarter Boards, Stronger ROI, and China's Rise
As biotech models evolve, boards, clinical leaders, and investors are being forced to rethink how value is created. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Ross Pettit, Chief Development Officer, Kestrel Therapeutics, to explore how leaner operating models, sharper board governance, ROI‑driven clinical decisions, and the rapid rise of China’s biotech ecosystem are redefining what “modern biotech” looks like today.
#biotech #drugdevelopment #clinicaltrials #clinicaldevelopment #biotechstrategy #biotechleadership #clinicaloperations #ROI
#ChinaBiotech
View the video series and find out more information here: https://www.citeline.com/biotech
22 Oct 2025
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation
Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CEO of Worldwide Clinical Trials as they reveal insider strategies for securing investors, navigating partnerships, and turning innovative science into real-world success.
View the video series and find out more information here: https://www.citeline.com/biotech
12 Sept 2025
Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech
What makes a biotech-CRO partnership truly work? Claire Riches, VP, Clinical Solutions, Citeline, and Matt Simmons, Senior Director, Oncology Strategy, IQVIA Biotech, share the secrets behind winning biotech-CRO partnerships, covering collaboration, transparent budgeting, regulatory navigation, and recruitment strategies, with essential insights to help biotechs succeed from their first RFP to global trials.
View the video series and find out more information here: https://www.citeline.com/biotech
30 Jun 2025
Master Regulatory Hurdles and Accelerate Your Drug Development
With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing real-world data, and finding new global pathways to bring therapies to life.
Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights.
View the video series and find out more information here: https://www.citeline.com/biotech
23 Jun 2025
How to Crush Competitive Threats and Stand Out in Biotech
The race for new therapies is more intense than ever. This episode uncovers how biotech and pharma use competitive intelligence, AI, and data to outsmart rivals and change the game.
Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights.
View the video series and find out more information here: https://www.citeline.com/biotech
11 Jun 2025
Strategies to Secure Critical Biotech Funding Amid Market Challenges
Biotechs are racing to change the rules in this tough market. This episode reveals how AI, real-world data, and strategic partnerships are reshaping drug development. Is reinvention biotech’s last hope?
Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights.
View the video series and find out more information here: https://www.citeline.com/biotech
11 Jun 2025
How to Survive Innovation Pressure in Today’s Biotech Landscape
Small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resilience are rising. This episode explores how biotechs ignite innovation despite economic headwinds, regulatory uncertainty, and fierce competition.
Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights.
View the video series and find out more information here: https://www.citeline.com/biotech
Contact Small Biotechs; Big Decisions
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Small Biotechs; Big Decisions?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
